During the past decade, Indiana Medical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana Medical Research" #1 sponsor was "Chelsea Therapeutics" with 2 trials, followed by "Cephalon" with 1 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "FUJIFILM Toyama Chemical Co., Ltd." with 1 trials sponsored and "Yale University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana Medical Research" #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "Takeda Pharmaceuticals North America, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Indiana Medical Research" are "Dopamine Beta Hydroxylase Deficiency" (2 trials), "Myocardial Infarction" (2 trials), "Acute Coronary Syndrome" (1 trials), "Alzheimer's Disease" (1 trials) and "Chronic Pain" (1 trials). Many other conditions were trialed in "Indiana Medical Research" in a lesser frequency.

Most popular intervention types in "Indiana Medical Research" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Droxidopa" (2 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Fentanyl Buccal Tablet" (1 trials) and "Immediate release oxycodone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Indiana Medical Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Indiana Medical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Indiana Medical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana Medical Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".